1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Branded Generics Market, by Product
6.1. Introduction
6.2. Trade Named Generics
6.3. Value-Added

7. Branded Generics Market, by Application
7.1. Introduction
7.2. Anti-Cancer
7.3. Anti-Infective
7.4. Cardiovascular
7.5. CNS

8. Branded Generics Market, by Distribution Channel
8.1. Introduction
8.2. Clinics
8.3. Hospital Pharmacy
8.4. Pharmacy

9. California Branded Generics Market

10. Florida Branded Generics Market

11. Illinois Branded Generics Market

12. New York Branded Generics Market

13. Ohio Branded Generics Market

14. Pennsylvania Branded Generics Market

15. Texas Branded Generics Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Amneal Pharmaceuticals
17.2. Apotex Inc.
17.3. AstraZeneca PLC
17.4. Aurobindo Pharma Limited
17.5. Bausch Health Companies Inc
17.6. Cadila Healthcare Limited
17.7. Cipla Inc
17.8. Dr. Reddy's Laboratories Ltd.
17.9. Endo International PLC
17.10. Eris Lifesciences Limited
17.11. Eva Pharma
17.12. Fresenius Kabi
17.13. GlaxoSmithKline PLC
17.14. Glenmark Pharmaceuticals Limited
17.15. Hetero Drugs Limited
17.16. Lupin Pharmaceuticals, Inc.
17.17. Mylan N.V.
17.18. Novartis International AG
17.19. Pfizer Inc
17.20. Sandoz International GmbH
17.21. Sanofi S.A.
17.22. STADA Arzneimittel AG
17.23. Strides Arcolab Ltd
17.24. Sun Pharmaceutical Industries Ltd
17.25. Teva Pharmaceutical Industries Ltd
17.26. Torrent Pharmaceuticals Ltd

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES BRANDED GENERICS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES BRANDED GENERICS MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES BRANDED GENERICS MARKET SIZE, BY PRODUCT , 2020 VS 2027 (%)
FIGURE 4. UNITED STATES BRANDED GENERICS MARKET SIZE, BY PRODUCT , 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BRANDED GENERICS MARKET SIZE, BY PRODUCT , 2027
FIGURE 6. UNITED STATES BRANDED GENERICS MARKET SIZE, BY TRADE NAMED GENERICS, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES BRANDED GENERICS MARKET SIZE, BY TRADE NAMED GENERICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES BRANDED GENERICS MARKET SIZE, BY VALUE-ADDED, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES BRANDED GENERICS MARKET SIZE, BY VALUE-ADDED, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 11. UNITED STATES BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2027
FIGURE 13. UNITED STATES BRANDED GENERICS MARKET SIZE, BY ANTI-CANCER, 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES BRANDED GENERICS MARKET SIZE, BY ANTI-CANCER, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVE, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES BRANDED GENERICS MARKET SIZE, BY CNS, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES BRANDED GENERICS MARKET SIZE, BY CNS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2027 (%)
FIGURE 22. UNITED STATES BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2027 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 24. UNITED STATES BRANDED GENERICS MARKET SIZE, BY CLINICS, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES BRANDED GENERICS MARKET SIZE, BY CLINICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES BRANDED GENERICS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES BRANDED GENERICS MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 28. UNITED STATES BRANDED GENERICS MARKET SIZE, BY PHARMACY, 2018-2027 (USD MILLION)
FIGURE 29. UNITED STATES BRANDED GENERICS MARKET SIZE, BY PHARMACY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 30. UNITED STATES BRANDED GENERICS MARKET: FPNV POSITIONING MATRIX
FIGURE 31. UNITED STATES BRANDED GENERICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 32. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES BRANDED GENERICS MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES BRANDED GENERICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES BRANDED GENERICS MARKET SIZE, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES BRANDED GENERICS MARKET SIZE, BY TRADE NAMED GENERICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES BRANDED GENERICS MARKET SIZE, BY VALUE-ADDED, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES BRANDED GENERICS MARKET SIZE, BY ANTI-CANCER, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVE, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES BRANDED GENERICS MARKET SIZE, BY CNS, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES BRANDED GENERICS MARKET SIZE, BY CLINICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES BRANDED GENERICS MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES BRANDED GENERICS MARKET SIZE, BY PHARMACY, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES BRANDED GENERICS MARKET: SCORES
TABLE 16. UNITED STATES BRANDED GENERICS MARKET: BUSINESS STRATEGY
TABLE 17. UNITED STATES BRANDED GENERICS MARKET: PRODUCT SATISFACTION
TABLE 18. UNITED STATES BRANDED GENERICS MARKET: RANKING
TABLE 19. UNITED STATES BRANDED GENERICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 20. UNITED STATES BRANDED GENERICS MARKET: MERGER & ACQUISITION
TABLE 21. UNITED STATES BRANDED GENERICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 22. UNITED STATES BRANDED GENERICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 23. UNITED STATES BRANDED GENERICS MARKET: INVESTMENT & FUNDING
TABLE 24. UNITED STATES BRANDED GENERICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 25. UNITED STATES BRANDED GENERICS MARKET: LICENSE & PRICING

Companies Mentioned

Amneal Pharmaceuticals
Apotex Inc.
AstraZeneca PLC
Aurobindo Pharma Limited
Bausch Health Companies Inc
Cadila Healthcare Limited
Cipla Inc
Dr. Reddy's Laboratories Ltd.
Endo International PLC
Eris Lifesciences Limited
Eva Pharma
Fresenius Kabi
GlaxoSmithKline PLC
Glenmark Pharmaceuticals Limited
Hetero Drugs Limited
Lupin Pharmaceuticals, Inc.
Mylan N.V.
Novartis International AG
Pfizer Inc
Sandoz International GmbH
Sanofi S.A.
STADA Arzneimittel AG
Strides Arcolab Ltd
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd